The Board proposes the rule amendment to delete language that will be added to Rule 64B13-3.010, Standards of Practice and to renumber the rule accordingly.

 

DEPARTMENT OF HEALTH

Board of Optometry

RULE NO.:RULE TITLE:

64B13-10.002Administration and Prescription of Ocular Pharmaceutical Agents

PURPOSE AND EFFECT: The Board proposes the rule amendment to delete language that will be added to Rule 64B13-3.010, F.A.C., Standards of Practice and to renumber the rule accordingly.

SUMMARY: The rule amendment will delete language that will be added to Rule 64B13-3.010, F.A.C., Standards of Practice and to renumber the rule accordingly.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION: The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 463.005(1), 463.0055 FS.

LAW IMPLEMENTED: 463.0055, 463.012, 463.016(1)(g), (k) FS.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Anthony Spivey, D.B.A., Executive Director, Board of Optometry/MQA, 4052 Bald Cypress Way, Bin # C07, Tallahassee, Florida 32399-3257

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B13-10.002 Administration and Prescription of Ocular Pharmaceutical Agents

(1) Only a certified optometrist may administer and prescribe ocular pharmaceutical agents. A licensed practitioner who is not certified may use topically applied anesthetics solely for the purpose of glaucoma examinations, but is otherwise prohibited from administering or prescribing ocular pharmaceutical agents. Certified optometrists may administer and prescribe only those ocular pharmaceutical agents identified by rule of the Board and oral ocular pharmaceutical agents listed in the statutory formulary.

(1)(2) No change

(2)(3) No change

(4)(a) Any prescription for an ocular pharmaceutical agent written by a certified optometrist shall contain the following information:

1. Name of the person for whom the pharmaceutical agent is prescribed;

2. Full name and address of the prescribing certified optometrist;

3. Name of the ocular pharmaceutical agent prescribed and the strength, quantity, and directions for use thereof; and

4. Prescriber number and signature of the prescribing certified optometrist.

(b) All written prescriptions must comply with the requirements of Sections 456.42 and 893.04, F.S.

(5) When an ocular pharmaceutical agent is either administered or prescribed to a patient by a certified optometrist, such shall be documented in the patients record.

Rulemaking Authority 463.005(1), 463.0055 FS. Law Implemented 463.0055, 463.012, 463.016(1)(g), (k) FS. History–New 11-20-86, Formerly 21Q-10.002, 61F8-10.002, 59V-10.002, Amended 10-28-09, 12-9-13,                         .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Optometry

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Optometry

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: December 4, 2015

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: February 3, 2016